A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
NCT00044135 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2005-06-24
Summary
The purpose of the study is to evaluate the safety and effectiveness of 12 weeks of treatment with clevudine, at one of three doses, in patients chronically infected with hepatitis B virus.
Conditions
Interventions
- DRUG
-
clevudine (drug)
Sponsors & Collaborators
-
Triangle Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-08-31
Countries
- United States
- Canada
- China
- France
- Singapore
Study Locations
More Related Trials
-
Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV
NCT00501124 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
NCT00362505 ·Status: TERMINATED ·Phase: PHASE3
-
ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
NCT00823342 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV
NCT00313274 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
NCT00496158 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
NCT00496002 ·Status: TERMINATED ·Phase: PHASE3
-
An Study of Efficacy and Safety of Clevudine
NCT01192854 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function
NCT00641082 ·Status: COMPLETED ·Phase: PHASE4
-
Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients
NCT00558493 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group
NCT00313261 ·Status: TERMINATED ·Phase: PHASE2
-
Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
NCT00362635 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients
NCT00798460 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201
NCT00362700 ·Status: TERMINATED ·Phase: PHASE2
-
A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B
NCT00672867 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)
NCT01264367 ·Status: COMPLETED ·Phase: PHASE4
-
A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC
NCT01263002 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Healthy Volunteers
NCT03596697 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Lamivudine Therapy for Chronic Hepatitis B
NCT00120354 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period
NCT01264094 ·Status: TERMINATED ·Phase: PHASE4
-
Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects
NCT02202473 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Telbivudine in Chronic Hepatitis B
NCT00970216 ·Status: COMPLETED
-
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
NCT00907894 ·Status: COMPLETED ·Phase: PHASE1
-
Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection
NCT00023153 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection
NCT01651403 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B
NCT00124241 ·Status: COMPLETED ·Phase: PHASE2